Kidney Disease in Type 2 Diabetes Mellitus and Benefits of Sodium-Glucose Cotransporter 2 Inhibitors: A Consensus Statement

Diabetic kidney disease (DKD) occurs in approximately 20–40% of patients with type 2 diabetes mellitus. Patients with DKD have a higher risk of cardiovascular and all-cause mortality. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and antihyperglycemic drugs form the mains...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, Ajitesh, Maiti, Animesh, Sinha, Anirban, Baidya, Arjun, Basu, Asish Kumar, Sarkar, Dasarathi, Sanyal, Debmalya, Biswas, Dibakar, Maisnam, Indira, Pandit, Kaushik, Raychaudhuri, Moutusi, Sengupta, Nilanjan, Chakraborty, Partha Pratim, Mukhopadhyay, Pradip, Raychaudhuri, Pradip, Sahana, Pranab Kumar, Chatterjee, Purushottam, Bhattacharjee, Rana, Dasgupta, Ranen, Saraogi, Ravi Kant, Pal, Salil Kumar, Mukhopadhyay, Sarmishtha, Mukhopadhyay, Satinath, Goswami, Soumik, Chowdhury, Subhankar, Ghosh, Sujoy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644753/
https://www.ncbi.nlm.nih.gov/pubmed/33025397
http://dx.doi.org/10.1007/s13300-020-00921-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644753/
https://www.ncbi.nlm.nih.gov/pubmed/33025397
http://dx.doi.org/10.1007/s13300-020-00921-y

Ejemplares similares